GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Price-to-Owner-Earnings

Fabino Life Sciences (BOM:543444) Price-to-Owner-Earnings : (As of Jun. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Price-to-Owner-Earnings?

As of today (2024-06-14), Fabino Life Sciences's share price is ₹28.00. Fabino Life Sciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Fabino Life Sciences's Price-to-Owner-Earnings or its related term are showing as below:


BOM:543444's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.01
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-14), Fabino Life Sciences's share price is ₹28.00. Fabino Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.17. Therefore, Fabino Life Sciences's PE Ratio for today is 164.71.

As of today (2024-06-14), Fabino Life Sciences's share price is ₹28.00. Fabino Life Sciences's EPS without NRI for the trailing twelve months (TTM) ended in was ₹0.17. Therefore, Fabino Life Sciences's PE Ratio without NRI for today is 164.71.

During the past 6 years, Fabino Life Sciences's highest PE Ratio without NRI was 876.80. The lowest was 106.82. And the median was 164.71.


Fabino Life Sciences Price-to-Owner-Earnings Historical Data

The historical data trend for Fabino Life Sciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Price-to-Owner-Earnings Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Fabino Life Sciences's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Life Sciences's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Price-to-Owner-Earnings falls into.



Fabino Life Sciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Fabino Life Sciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=28.00/-4.23
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences  (BOM:543444) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Fabino Life Sciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines